151 related articles for article (PubMed ID: 33798233)
1. Effects of time to chemoradiation on high-grade gliomas from the Buenos Aires Metropolitan Area.
Prost DM; Merenzon MA; Gómez-Escalante JI; Primavera A; Vargas Benítez M; Gil AS; Marenco PM; Califano MM; Moughty Cueto C; Zaloff Dakoff JM; Colonna M; Mazzón A; Zaninovich RS; De Cristófaro OR
PLoS One; 2021; 16(4):e0249486. PubMed ID: 33798233
[TBL] [Abstract][Full Text] [Related]
2. Tumor treating fields for newly diagnosed high-grade glioma based on the criteria of 2021 WHO CNS5: A retrospective analysis of Chinese patients in a single center.
Zhang L; Ren Y; Peng Y; Luo Y; Liu Y; Wang X; Yang Y; Liu L; Ai P; Yang X; Li Y; Mao Q; Wang F
Cancer Med; 2024 Jun; 13(11):e7350. PubMed ID: 38859683
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
4. Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945.
Eisenstat DD; Pollack IF; Demers A; Sapp MV; Lambert P; Weisfeld-Adams JD; Burger PC; Gilles F; Davis RL; Packer R; Boyett JM; Finlay JL
J Neurooncol; 2015 Feb; 121(3):573-81. PubMed ID: 25431150
[TBL] [Abstract][Full Text] [Related]
5. Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424.
Fisher BJ; Pugh SL; Macdonald DR; Chakravatri A; Lesser GJ; Fox S; Rogers CL; Werner-Wasik M; Doyle T; Bahary JP; Fiveash JB; Bovi JA; Howard SP; Michael Yu HH; D'Souza D; Laack NN; Barani IJ; Kwok Y; Wahl DR; Strasser JF; Won M; Mehta MP
Int J Radiat Oncol Biol Phys; 2020 Jul; 107(4):720-725. PubMed ID: 32251755
[TBL] [Abstract][Full Text] [Related]
6. Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide.
Speirs CK; Simpson JR; Robinson CG; DeWees TA; Tran DD; Linette G; Chicoine MR; Dacey RG; Rich KM; Dowling JL; Leuthardt EC; Zipfel GJ; Kim AH; Huang J
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):268-76. PubMed ID: 25636755
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma.
Ji N; Weng D; Liu C; Gu Z; Chen S; Guo Y; Fan Z; Wang X; Chen J; Zhao Y; Zhou J; Wang J; Ma D; Li N
Oncotarget; 2016 Jan; 7(4):4369-78. PubMed ID: 26716896
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma.
Lee YP; Jung HA; Lee MS; Choi JW; Kong DS; Seol HJ; Nam DH; Lee JI; Lee SH
J Neurooncol; 2022 Feb; 156(3):541-549. PubMed ID: 35094201
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.
Eatz TA; Eichberg DG; Lu VM; Di L; Komotar RJ; Ivan ME
J Neurooncol; 2022 Jan; 156(2):233-256. PubMed ID: 34989964
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas.
Wang JL; Barth RF; Cavaliere R; Puduvalli VK; Giglio P; Lonser RR; Elder JB
PLoS One; 2020; 15(12):e0244383. PubMed ID: 33373402
[TBL] [Abstract][Full Text] [Related]
11. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
[TBL] [Abstract][Full Text] [Related]
12. Analysis of factors influencing the access to concomitant chemo-radiotherapy in elderly patients with high grade gliomas: role of MMSE, age and tumor volume.
Di Cristofori A; Zarino B; Fanizzi C; Fornara GA; Bertani G; Rampini P; Carrabba G; Caroli M
J Neurooncol; 2017 Sep; 134(2):377-385. PubMed ID: 28685404
[TBL] [Abstract][Full Text] [Related]
13. High-grade Glioma - A decade of care in Christchurch.
Yan SS; James ML; Kerstens P; de Lambert M; Robinson BA; Yi M
J Med Imaging Radiat Oncol; 2019 Oct; 63(5):665-673. PubMed ID: 31464076
[TBL] [Abstract][Full Text] [Related]
14. Changes in presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty years.
Youland RS; Schomas DA; Brown PD; Nwachukwu C; Buckner JC; Giannini C; Parney IF; Laack NN
Neuro Oncol; 2013 Aug; 15(8):1102-10. PubMed ID: 23814262
[TBL] [Abstract][Full Text] [Related]
15. Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base.
Jhaveri J; Liu Y; Chowdhary M; Buchwald ZS; Gillespie TW; Olson JJ; Voloschin AD; Eaton BR; Shu HG; Crocker IR; Curran WJ; Patel KR
Cancer; 2018 Mar; 124(6):1169-1178. PubMed ID: 29205287
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy versus radiotherapy combined with temozolomide in high-risk low-grade gliomas after surgery: study protocol for a randomized controlled clinical trial.
Wang J; Wang Y; He Y; Guan H; He L; Mu X; Peng X
Trials; 2019 Nov; 20(1):641. PubMed ID: 31752981
[TBL] [Abstract][Full Text] [Related]
17. Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas.
Wang C; Liu S; Peng L; Zhang K; Li W; Zhang H; Luan Y; Li P; Hu X
BMC Cancer; 2020 Jun; 20(1):591. PubMed ID: 32580723
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Molecular Markers in High Grade Gliomas with Response to Chemo-Radiation.
Khurana R; Rath S; Singh HB; Rastogi M; Nanda SS; Chauhan A; Kaif M; Hussain N
Asian Pac J Cancer Prev; 2020 Mar; 21(3):755-760. PubMed ID: 32212804
[TBL] [Abstract][Full Text] [Related]
19. Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.
Schernberg A; Dhermain F; Ammari S; Dumont SN; Domont J; Patrikidou A; Pallud J; Dezamis É; Deutsch É; Louvel G
Cancer Radiother; 2018 Feb; 22(1):9-16. PubMed ID: 29217134
[TBL] [Abstract][Full Text] [Related]
20. Sequential proton boost after standard chemoradiation for high-grade glioma.
Adeberg S; Bernhardt D; Harrabi SB; Uhl M; Paul A; Bougatf N; Verma V; Unterberg A; Wick W; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
Radiother Oncol; 2017 Nov; 125(2):266-272. PubMed ID: 29050959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]